Funding Announcements

"UTI prevalence is rising with an ageing population and the increase in antibiotic resistant infections. The gold standard for UTI diagnosis is microbiological urine culture and, in the UK, millions of urine tests are processed and cultured each year. However, a major drawback of urine culture systems is the time lag of approximately two days between specimen collection and pathogen identification. Fast and accurate diagnosis, leading to a rational treatment, is essential to achieve a timely and effective therapy."

"Our investment into Purespring Therapeutics fits perfectly into our strategy to support the UK’s life sciences and is the type of UK growth company which could benefit further by unlocking the potential of institutional investment. We need to support companies like Purespring as they go through development and trials before coming to market.Providing that capital simultaneously stimulates growth and helps to solve pressing medical challenges that will deliver long-term outcomes for generations to come."

"We are pushing past AI’s limits in biological design by doubling down on solving the fundamental data gap that the entire biotech industry faces, Basecamp Research is using its technology to generate new and deeper insights, going beyond known biology and each day expand what we can offer to our partners in the biopharma ecosystem."

"Perlego is addressing one of the most pressing challenges in modern education – access to essential learning materials. This investment is a vote of confidence in Perlego’s innovative approach to learning and the platform’s potential to reshape the educational landscape. Investing in the futures of young people has always been a passion of mine, and I am particularly committed to funding research in areas of regional disparity. I look forward to seeing how the business continues to transform access to education and I am incredibly proud to play a part in the journey that aligns so closely with my own values."